세계의 비타민 B12 보충제 시장 : 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for Vitamin B12 supplements. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Vitamin B12 Supplement Market Size (2024E): USD 304.8 Million
• Projected Market Value (2033F): USD 549 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 6.8%

Vitamin B12 Supplement Market - Report Scope:

Vitamin B12 supplements play a crucial role in addressing deficiencies that can lead to serious health issues, including anemia, neurological disorders, and cognitive decline. These supplements are essential for individuals with certain dietary restrictions, such as vegans and vegetarians, as well as older adults who may have decreased absorption capabilities. The Vitamin B12 supplement market caters to pharmacies, health food stores, online retailers, and direct sales channels, offering a range of product forms, including tablets, capsules, liquid drops, and injectables.

Market Growth Drivers:

The global Vitamin B12 supplement market is propelled by several key factors, including the increasing awareness of the health benefits of Vitamin B12, particularly in the context of preventing deficiencies that can cause severe health complications. The rising prevalence of vegan and vegetarian diets, which often lack sufficient B12 sources, further drives market expansion. Technological advancements in supplement formulations, such as the development of highly bioavailable forms of B12 like methylcobalamin, enhance absorption and efficacy, fostering market growth. Moreover, the growing trend of preventive healthcare and the increasing consumer preference for dietary supplements boost market demand.

Market Restraints:

Despite promising growth prospects, the Vitamin B12 supplement market faces challenges related to regulatory compliance, consumer misinformation, and the high cost of certain supplement formulations. Stringent regulations governing the manufacturing, labeling, and marketing of dietary supplements impose compliance burdens on manufacturers and can affect market entry barriers and operational costs. Furthermore, misinformation regarding the necessity and efficacy of supplements can lead to consumer skepticism, hindering market penetration. Addressing these regulatory and informational barriers requires collaboration between industry stakeholders, healthcare providers, and policymakers to promote access to safe and effective Vitamin B12 supplements.

Market Opportunities:

The Vitamin B12 supplement market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as personalized nutrition apps and telehealth services, enhances consumer access to dietary supplements and improves adherence to supplementation regimens. Furthermore, the expanding application of Vitamin B12 beyond deficiency treatment, including its potential role in enhancing cognitive function and energy levels, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective supplement forms are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic supplement landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Vitamin B12 supplement market globally?
• Which product forms and distribution channels are driving supplement adoption across different consumer segments?
• How are technological advancements reshaping the competitive landscape of the Vitamin B12 supplement market?
• Who are the key players contributing to the Vitamin B12 supplement market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global Vitamin B12 supplement market?

Competitive Intelligence and Business Strategy:

Leading players in the global Vitamin B12 supplement market, including Pfizer Inc., Nature's Bounty, and Garden of Life, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced supplement formulations, including chewable tablets, fast-dissolve capsules, and high-potency liquid drops, catering to diverse consumer needs and preferences. Collaborations with healthcare providers, retailers, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based marketing, and consumer education fosters market growth and enhances consumer trust in the rapidly evolving supplement landscape.

Key Companies Profiled:

• Chem Kart India Pvt Ltd
• Pfizer Inc.
• Sanofi-Aventis
• Bristol-Myers Squibb Company
• Konikilijke DSM N.V.
• Johnlee Pharmaceutical Pvt Ltd.
• Charkit Chemical.
• American Regent
• Apotheca Inc.
• Merck Group

Segmentation of the Global Vitamin B12 Supplement Market:

By Form

• Tablet
• Powder
• Liquid
• Capsule

By End Use Industry

• Fortified Food & Beverages
• Pharmaceutical
• Health And Personal Care
• Agriculture, Animal Feed, Poultry

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Investment Feasibility Matrix
• 3.5. PESTLE and Porter's Analysis
• 3.6. Regulatory Landscape
  • 3.6.1. By Key Regions
  • 3.6.2. By Key Countries
• 3.7. Regional Parent Market Outlook

4. Global Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast, 2024-2033

• 4.1. Historical Market Size Value (US$ Million) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024-2033
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast 2024-2033, By Form

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Million) Analysis By Form, 2019-2023
• 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Form, 2024-2033
  • 5.3.1. Powder
  • 5.3.2. Capsule
  • 5.3.3. Liquid
  • 5.3.4. Tablet
• 5.4. Y-o-Y Growth Trend Analysis By Form, 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Form, 2024-2033

6. Global Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast 2024-2033, By End Use Industry

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Million) Analysis By End Use Industry, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use Industry, 2024-2033
  • 6.3.1. Food & Beverages
  • 6.3.2. Pharmaceutical
  • 6.3.3. Health & Personal Care
  • 6.3.4. Agriculture/Animal Feed/Poultry
• 6.4. Y-o-Y Growth Trend Analysis By End Use Industry, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By End Use Industry, 2024-2033

7. Global Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 7.1. Introduction
• 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019-2023
• 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024-2033
  • 7.3.1. North America
  • 7.3.2. Latin America
  • 7.3.3. Europe
  • 7.3.4. Asia Pacific
  • 7.3.5. MEA
• 7.4. Market Attractiveness Analysis By Region

8. North America Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
• 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2033
  • 8.2.1. By Country
    • 8.2.1.1. U.S.
    • 8.2.1.2. Canada
  • 8.2.2. By Form
  • 8.2.3. By End Use Industry
• 8.3. Market Attractiveness Analysis
  • 8.3.1. By Country
  • 8.3.2. By Form
  • 8.3.3. By End Use Industry
• 8.4. Key Takeaways

9. Latin America Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
• 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2033
  • 9.2.1. By Country
    • 9.2.1.1. Brazil
    • 9.2.1.2. Mexico
    • 9.2.1.3. Rest of Latin America
  • 9.2.2. By Form
  • 9.2.3. By End Use Industry
• 9.3. Market Attractiveness Analysis
  • 9.3.1. By Country
  • 9.3.2. By Form
  • 9.3.3. By End Use Industry
• 9.4. Key Takeaways

10. Europe Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2033
  • 10.2.1. By Country
    • 10.2.1.1. Germany
    • 10.2.1.2. U.K.
    • 10.2.1.3. France
    • 10.2.1.4. Spain
    • 10.2.1.5. Italy
    • 10.2.1.6. Rest of Europe
  • 10.2.2. By Form
  • 10.2.3. By End Use Industry
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Form
  • 10.3.3. By End Use Industry
• 10.4. Key Takeaways

11. Asia Pacific Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2033
  • 11.2.1. By Country
    • 11.2.1.1. China
    • 11.2.1.2. Japan
    • 11.2.1.3. South Korea
    • 11.2.1.4. Singapore
    • 11.2.1.5. Thailand
    • 11.2.1.6. Indonesia
    • 11.2.1.7. Australia
    • 11.2.1.8. New Zealand
    • 11.2.1.9. Rest of Asia Pacific
  • 11.2.2. By Form
  • 11.2.3. By End Use Industry
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Form
  • 11.3.3. By End Use Industry
• 11.4. Key Takeaways

12. MEA Vitamin B12 Supplements Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2033
  • 12.2.1. By Country
    • 12.2.1.1. GCC Countries
    • 12.2.1.2. South Africa
    • 12.2.1.3. Israel
    • 12.2.1.4. Rest of MEA
  • 12.2.2. By Form
  • 12.2.3. By End Use Industry
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Form
  • 12.3.3. By End Use Industry
• 12.4. Key Takeaways

13. Key Countries Vitamin B12 Supplements Market Analysis

• 13.1. U.S.
  • 13.1.1. Pricing Analysis
  • 13.1.2. Market Share Analysis, 2024
    • 13.1.2.1. By Form
    • 13.1.2.2. By End Use Industry
• 13.2. Canada
  • 13.2.1. Pricing Analysis
  • 13.2.2. Market Share Analysis, 2024
    • 13.2.2.1. By Form
    • 13.2.2.2. By End Use Industry
• 13.3. Brazil
  • 13.3.1. Pricing Analysis
  • 13.3.2. Market Share Analysis, 2024
    • 13.3.2.1. By Form
    • 13.3.2.2. By End Use Industry
• 13.4. Mexico
  • 13.4.1. Pricing Analysis
  • 13.4.2. Market Share Analysis, 2024
    • 13.4.2.1. By Form
    • 13.4.2.2. By End Use Industry
• 13.5. Germany
  • 13.5.1. Pricing Analysis
  • 13.5.2. Market Share Analysis, 2024
    • 13.5.2.1. By Form
    • 13.5.2.2. By End Use Industry
• 13.6. U.K.
  • 13.6.1. Pricing Analysis
  • 13.6.2. Market Share Analysis, 2024
    • 13.6.2.1. By Form
    • 13.6.2.2. By End Use Industry
• 13.7. France
  • 13.7.1. Pricing Analysis
  • 13.7.2. Market Share Analysis, 2024
    • 13.7.2.1. By Form
    • 13.7.2.2. By End Use Industry
• 13.8. Spain
  • 13.8.1. Pricing Analysis
  • 13.8.2. Market Share Analysis, 2024
    • 13.8.2.1. By Form
    • 13.8.2.2. By End Use Industry
• 13.9. Italy
  • 13.9.1. Pricing Analysis
  • 13.9.2. Market Share Analysis, 2024
    • 13.9.2.1. By Form
    • 13.9.2.2. By End Use Industry
• 13.10. China
  • 13.10.1. Pricing Analysis
  • 13.10.2. Market Share Analysis, 2024
    • 13.10.2.1. By Form
    • 13.10.2.2. By End Use Industry
• 13.11. Japan
  • 13.11.1. Pricing Analysis
  • 13.11.2. Market Share Analysis, 2024
    • 13.11.2.1. By Form
    • 13.11.2.2. By End Use Industry
• 13.12. South Korea
  • 13.12.1. Pricing Analysis
  • 13.12.2. Market Share Analysis, 2024
    • 13.12.2.1. By Form
    • 13.12.2.2. By End Use Industry
• 13.13. Singapore
  • 13.13.1. Pricing Analysis
  • 13.13.2. Market Share Analysis, 2024
    • 13.13.2.1. By Form
    • 13.13.2.2. By End Use Industry
• 13.14. Thailand
  • 13.14.1. Pricing Analysis
  • 13.14.2. Market Share Analysis, 2024
    • 13.14.2.1. By Form
    • 13.14.2.2. By End Use Industry
• 13.15. Indonesia
  • 13.15.1. Pricing Analysis
  • 13.15.2. Market Share Analysis, 2024
    • 13.15.2.1. By Form
    • 13.15.2.2. By End Use Industry
• 13.16. Australia
  • 13.16.1. Pricing Analysis
  • 13.16.2. Market Share Analysis, 2024
    • 13.16.2.1. By Form
    • 13.16.2.2. By End Use Industry
• 13.17. New Zealand
  • 13.17.1. Pricing Analysis
  • 13.17.2. Market Share Analysis, 2024
    • 13.17.2.1. By Form
    • 13.17.2.2. By End Use Industry
• 13.18. GCC Countries
  • 13.18.1. Pricing Analysis
  • 13.18.2. Market Share Analysis, 2024
    • 13.18.2.1. By Form
    • 13.18.2.2. By End Use Industry
• 13.19. South Africa
  • 13.19.1. Pricing Analysis
  • 13.19.2. Market Share Analysis, 2024
    • 13.19.2.1. By Form
    • 13.19.2.2. By End Use Industry
• 13.20. Israel
  • 13.20.1. Pricing Analysis
  • 13.20.2. Market Share Analysis, 2024
    • 13.20.2.1. By Form
    • 13.20.2.2. By End Use Industry

14. Market Structure Analysis

• 14.1. Competition Dashboard
• 14.2. Competition Benchmarking
• 14.3. Market Share Analysis of Top Players
  • 14.3.1. By Regional
  • 14.3.2. By Form
  • 14.3.3. By End Use Industry

15. Competition Analysis

• 15.1. Competition Deep Dive
  • 15.1.1. Apotheca Inc.
    • 15.1.1.1. Overview
    • 15.1.1.2. Product Portfolio
    • 15.1.1.3. Profitability by Market Segments
    • 15.1.1.4. Sales Footprint
    • 15.1.1.5. Strategy Overview
      • 15.1.1.5.1. Marketing Strategy
  • 15.1.2. Merck Group
    • 15.1.2.1. Overview
    • 15.1.2.2. Product Portfolio
    • 15.1.2.3. Profitability by Market Segments
    • 15.1.2.4. Sales Footprint
    • 15.1.2.5. Strategy Overview
      • 15.1.2.5.1. Marketing Strategy
  • 15.1.3. Charkit Chemical Company LLC
    • 15.1.3.1. Overview
    • 15.1.3.2. Product Portfolio
    • 15.1.3.3. Profitability by Market Segments
    • 15.1.3.4. Sales Footprint
    • 15.1.3.5. Strategy Overview
      • 15.1.3.5.1. Marketing Strategy
  • 15.1.4. Johnlee Pharmaceuticals Pvt. Ltd.
    • 15.1.4.1. Overview
    • 15.1.4.2. Product Portfolio
    • 15.1.4.3. Profitability by Market Segments
    • 15.1.4.4. Sales Footprint
    • 15.1.4.5. Strategy Overview
      • 15.1.4.5.1. Marketing Strategy
  • 15.1.5. American Regent, Inc.
    • 15.1.5.1. Overview
    • 15.1.5.2. Product Portfolio
    • 15.1.5.3. Profitability by Market Segments
    • 15.1.5.4. Sales Footprint
    • 15.1.5.5. Strategy Overview
      • 15.1.5.5.1. Marketing Strategy
  • 15.1.6. Koninklijke DSM N.V.
    • 15.1.6.1. Overview
    • 15.1.6.2. Product Portfolio
    • 15.1.6.3. Profitability by Market Segments
    • 15.1.6.4. Sales Footprint
    • 15.1.6.5. Strategy Overview
      • 15.1.6.5.1. Marketing Strategy
  • 15.1.7. Bristol-Myers Squibb Company
    • 15.1.7.1. Overview
    • 15.1.7.2. Product Portfolio
    • 15.1.7.3. Profitability by Market Segments
    • 15.1.7.4. Sales Footprint
    • 15.1.7.5. Strategy Overview
      • 15.1.7.5.1. Marketing Strategy
  • 15.1.8. Sanofi-Aventis
    • 15.1.8.1. Overview
    • 15.1.8.2. Product Portfolio
    • 15.1.8.3. Profitability by Market Segments
    • 15.1.8.4. Sales Footprint
    • 15.1.8.5. Strategy Overview
      • 15.1.8.5.1. Marketing Strategy
  • 15.1.9. Pfizer Inc.
    • 15.1.9.1. Overview
    • 15.1.9.2. Product Portfolio
    • 15.1.9.3. Profitability by Market Segments
    • 15.1.9.4. Sales Footprint
    • 15.1.9.5. Strategy Overview
      • 15.1.9.5.1. Marketing Strategy
  • 15.1.10. Chemkart India Pvt. Ltd.
    • 15.1.10.1. Overview
    • 15.1.10.2. Product Portfolio
    • 15.1.10.3. Profitability by Market Segments
    • 15.1.10.4. Sales Footprint
    • 15.1.10.5. Strategy Overview
      • 15.1.10.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology